List of works - Ruth Lopert

A framework for assessing the impact of pharmaceutical reimbursement policies on incentives to innovate

scientific article published on 5 October 2015

A randomized controlled trial of piroxicam in the management of acute ankle sprain in Australian Regular Army recruits. The Kapooka Ankle Sprain Study

scientific article published on 01 July 1997

Adapting pharmaceutical reimbursement policies to manage spending on high-priced drugs.

scientific article published on 5 October 2015

Benefit and risks of trivalent 2010 seasonal influenza vaccine in Australian children ⬇️

scientific article published on 07 October 2010

Biosimilars and the European experience: implications for the United States

scientific article published on 01 October 2013

Child influenza vaccination. Panvax febrile reactions not a predictor

scientific article published on 21 July 2010

Comparative effectiveness research and evidence-based health policy: experience from four countries

scientific article

Costs of new treatments for hepatitis C infection

scientific article published on 01 November 2014

Costs to Australian taxpayers of pharmaceutical monopolies and proposals to extend them in the Trans-Pacific Partnership Agreement.

scientific article published on April 2015

Differential pricing of drugs: a role for cost-effectiveness analysis?

scientific article published in The Lancet

Disinvestment and Value-Based Purchasing Strategies for Pharmaceuticals: An International Review

scientific article published on 06 June 2015

Drug-induced delirium. Incidence, management and prevention.

scientific article published on October 1996

Faecal microbiota transplantation: a sui generis biological drug, not a tissue.

scientific article published on 20 May 2014

Implementing health technology assessment in Ghana to support universal health coverage: building relationships that focus on people, policy, and process

scientific article published on 28 November 2019

International Price Comparisons for Novel and Follow-on Drugs: A Response

Intussusception risk and disease prevention associated with rotavirus vaccines in Australia's National Immunization Program.

scientific article published on 26 August 2013

Medication information for patients with limited English proficiency: lessons from the European Union.

scientific article

PBS copayments and safety nets

scientific article published on 01 May 2009

Pharma's next frontier? New threats to public health in the Regional Comprehensive Economic Partnership agreement

scientific article published on 11 October 2015

Prices for innovative pharmaceutical products that provide health gain: a comparison between Australia and the United States

scientific article published on November 2007

Reply by authors

scientific article published on 25 January 2014

Revolution then evolution: the advance of health economic evaluation in Australia

scientific article published on 20 September 2014

The International Decision Support Initiative Reference Case for Economic Evaluation: An Aid to Thought.

scientific article published on December 2016

The Regional Comprehensive Economic Partnership, Intellectual Property Protection, and Access to Medicines.

scientific article

The Trans Pacific Partnership Agreement and access to HIV treatment in Vietnam

scientific article published on 14 November 2016

The high price of "free" trade: U.S. trade agreements and access to medicines.

scientific article

Transferability of results of cost utility analyses for biologicals in inflammatory conditions for Central and Eastern European countries

scientific article published on 16 May 2014

Use of pharmacoeconomics in prescribing research. Part 3: Cost-effectiveness analysis--a technique for decision-making at the margin

scientific article published on 01 June 2003

Use of pharmacoeconomics in prescribing research. Part 5: modelling--beyond clinical trials.

scientific article published on October 2003

What is fair? Choice, fairness, and transparency in access to prescription medicines in the United States and Australia.

scientific article published on January 2007

Willingness to pay for cancer therapy

scientific article published on 01 August 2012

List of works by Ruth Lopert

A framework for assessing the impact of pharmaceutical reimbursement policies on incentives to innovate

A randomized controlled trial of piroxicam in the management of acute ankle sprain in Australian Regular Army recruits. The Kapooka Ankle Sprain Study

Adapting pharmaceutical reimbursement policies to manage spending on high-priced drugs.

Benefit and risks of trivalent 2010 seasonal influenza vaccine in Australian children ⬇️

Biosimilars and the European experience: implications for the United States

Child influenza vaccination. Panvax febrile reactions not a predictor

Comparative effectiveness research and evidence-based health policy: experience from four countries

Costs of new treatments for hepatitis C infection

Costs to Australian taxpayers of pharmaceutical monopolies and proposals to extend them in the Trans-Pacific Partnership Agreement.

Differential pricing of drugs: a role for cost-effectiveness analysis?

Disinvestment and Value-Based Purchasing Strategies for Pharmaceuticals: An International Review

Drug-induced delirium. Incidence, management and prevention.

Faecal microbiota transplantation: a sui generis biological drug, not a tissue.

Implementing health technology assessment in Ghana to support universal health coverage: building relationships that focus on people, policy, and process

International Price Comparisons for Novel and Follow-on Drugs: A Response

Intussusception risk and disease prevention associated with rotavirus vaccines in Australia's National Immunization Program.

Medication information for patients with limited English proficiency: lessons from the European Union.

PBS copayments and safety nets

Pharma's next frontier? New threats to public health in the Regional Comprehensive Economic Partnership agreement

Prices for innovative pharmaceutical products that provide health gain: a comparison between Australia and the United States

Reply by authors

Revolution then evolution: the advance of health economic evaluation in Australia

The International Decision Support Initiative Reference Case for Economic Evaluation: An Aid to Thought.

The Regional Comprehensive Economic Partnership, Intellectual Property Protection, and Access to Medicines.

The Trans Pacific Partnership Agreement and access to HIV treatment in Vietnam

The high price of "free" trade: U.S. trade agreements and access to medicines.

Transferability of results of cost utility analyses for biologicals in inflammatory conditions for Central and Eastern European countries

Use of pharmacoeconomics in prescribing research. Part 3: Cost-effectiveness analysis--a technique for decision-making at the margin

Use of pharmacoeconomics in prescribing research. Part 5: modelling--beyond clinical trials.

What is fair? Choice, fairness, and transparency in access to prescription medicines in the United States and Australia.

Willingness to pay for cancer therapy